Ethics statement
The study protocol has been approved by the Institutional Review Board (IRB) of Catholic Medical Center (IRB number: XC23DIDS0001). Patient informed consent will be obtained by the co-investigators authorized by the IRB of each participating center. An electronic case report form will be used to collect data that will ensure patient de-identification. The trial has been registered with clinicaltrials.gov (NCT05771974; date of registration, March 16, 2023) and Clinical Research Information Service (KCT0008371; date of registration, April 6, 2023).